Skip to main content
Premium Trial:

Request an Annual Quote

Southampton Wins BBSRC Funds for Optical Sequencing

NEW YORK (GenomeWeb News) – Scientists at the UK's University of Southampton will use £117,000 ($191,000) in funding from the Biotechnology and Biological Sciences Research Council to develop a novel optical single-strand DNA sequencing tool.

The university said that its Optoelectronics Research Centre (ORC) will work on the sequencing method, which will include the use of nanoscale structures to optically read single DNA strands. University researchers also will collaborate with Renishaw Diagnostics, which will provide materials and expertise.

"By optically 'reading' DNA directly, we hope to eliminate the complex biochemical processes currently used so that genomes can be sequenced much faster and more cheaply," ORC researcher Tracy Melvin said in a statement.

The grant was awarded through the BBSRC's Strategic Tools and Resources Development Fund.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.